Target intelligence / Profile preview

Tyrosine-protein phosphatase non-receptor type substrate 1 (SIRPA)

Target
SIRPA
Molecular classification
Receptor, Immunoglobulin superfamily
01

Overview

Tyrosine-protein phosphatase non-receptor type substrate 1 (SHPS-1), commonly known as Signal-regulatory protein alpha (SIRP-alpha) or CD172a, is a transmembrane glycoprotein predominantly expressed on myeloid cells, including macrophages, dendritic cells, and neutrophils, as well as in the central nervous system. It features three extracellular immunoglobulin-like domains and a cytoplasmic tail containing immunoreceptor tyrosine-based inhibitory motifs (ITIMs). Upon binding to its ligand CD47, which is widely expressed on healthy cells and overexpressed on cancer cells as a 'don't eat me' signal, SIRP-alpha undergoes tyrosine phosphorylation. This recruits and activates the Src homology 2 (SH2) domain-containing protein tyrosine phosphatases SHP-1 and SHP-2, initiating an inhibitory signaling cascade that suppresses macrophage-mediated phagocytosis.

In oncology, the CD47-SIRP-alpha axis serves as a critical innate immune checkpoint that cancer cells exploit to evade immune surveillance. Therapeutic strategies targeting SIRP-alpha, such as monoclonal antibodies (e.g., BI 765063, ADU-1805, and BMS-986351), aim to block the CD47-SIRP-alpha interaction. This blockade restores the phagocytic capacity of macrophages, particularly when combined with tumor-opsonizing antibodies (such as rituximab or cetuximab) that provide a pro-phagocytic 'eat me' signal. Because SIRP-alpha expression is largely restricted to myeloid cells and neurons, targeting SIRP-alpha offers a wider therapeutic window and avoids the severe hematological toxicities (such as anemia and thrombocytopenia) associated with direct CD47-targeting agents.

Other names
SHPS-1SHP substrate 1Signal-regulatory protein alphaSIRP-alphaCD172aCD172 antigen-like family member ABrain Ig-like molecule with tyrosine-based activation motifsBITMacrophage fusion receptorMFRMyD-1 antigenp84
02

Mechanism of action

Monoclonal antibodies targeting SIRP-alpha bind to its extracellular domain on myeloid cells, blocking its interaction with CD47 on tumor cells. This disrupts the inhibitory 'don't eat me' signal, promoting macrophage-mediated antibody-dependent cellular phagocytosis (ADCP) of cancer cells.

03

Biological functions

Signal transductionImmune responseCell adhesionPhagocytosis regulation
04

Disease associations

CancerInflammationAutoimmune diseaseInfection
05

Safety considerations

Potential off-target binding to neurons expressing SIRP-alphaCross-reactivity with other SIRP family members (e.g., SIRP-beta or SIRP-gamma)Risk of systemic inflammatory or autoimmune reactions due to macrophage activation
06

Interacting drugs

5 more in the full profile.

07

Biomarkers

SIRP-alpha expression on tumor-associated macrophagesCD47 expression on tumor cellsSIRP-alpha genetic polymorphisms (V1/V2 alleles)Receptor occupancy on peripheral blood monocytes

Beyond the preview

Go deeper on Tyrosine-protein phosphatase non-receptor type substrate 1 (SIRPA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tyrosine-protein phosphatase non-receptor type substrate 1 (SIRPA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call